Beyaert S, Loriot A, Magremanne M, Renwart W, et al. Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2025 Sep 3. doi: 10.1007/s00405-025-09655.
PMID: 40900323